INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2006

Creatine supplementation did not increase urinary excretion of the carcinogen N-nitrososarcosine

A double-blind, placebo-controlled study in healthy humans evaluated the urinary excretion of the carcinogen N-nitrososarcosine during creatine supplementation. Participants took a high dose of creatine (20 g/d) for one week followed by a low dose (5 g/d) for 20 weeks. Oral creatine ingestion did not systematically elevate urinary excretion of N-nitrososarcosine.

Study type
Double-blind, placebo-controlled trial
Who was studied
Healthy human volunteers
What was measured
Urinary N-nitrososarcosine excretion

THE PAPER

Oral creatine supplementation in humans does not elevate urinary excretion of the carcinogen N-nitrososarcosine.

Derave W, Vanden Eede E, Hespel P, Carmella SG, Hecht SS. Nutrition, 2006.

PubMed 16413752 ↗DOI 10.1016/j.nut.2005.10.004 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.